Advertisement
Screener

GALECTIN THERAPEUTICS INC. (GALT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

GALECTIN THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

GALECTIN THERAPEUTICS INC. (GALT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.02 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14

  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.02M shares, a 15.77% decline year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.21M shares, a 11.80% decline from fiscal 2024.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.37M shares, a 33.95% increase from fiscal 2023.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.02M shares, a 4.21% decline from fiscal 2022.
  • GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.07M shares, a 59.77% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
1.02M shares
10-Q · filed 2026-08-14
1.02M shares
derived: sum of 3 quarters · filed 2026-08-14
1.02M shares
derived: sum of 4 quarters · filed 2026-08-14
2026-03-311.02M shares
10-Q · filed 2026-05-15
1.02M shares
derived: sum of 2 quarters · filed 2026-05-15
1.02M shares
derived: sum of 3 quarters · filed 2026-05-15
1.02M shares
derived: sum of 4 quarters · filed 2026-05-15
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
0.00 shares
derived: sum of 2 quarters · filed 2026-03-31
0.00 shares
derived: sum of 3 quarters · filed 2026-03-31
1.21M shares
10-K · filed 2026-03-31
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
0.00 shares
derived: sum of 2 quarters · filed 2025-11-14
1.21M shares
10-Q · filed 2025-11-14
1.21M shares
derived: sum of 4 quarters · filed 2026-03-31
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
1.21M shares
10-Q · filed 2025-08-14
1.21M shares
derived: sum of 3 quarters · filed 2026-03-31
1.31M shares
derived: sum of 4 quarters · filed 2026-03-31
2025-03-311.21M shares
10-Q · filed 2025-05-15
1.21M shares
derived: sum of 2 quarters · filed 2026-03-31
1.31M shares
derived: sum of 3 quarters · filed 2026-03-31
1.34M shares
derived: sum of 4 quarters · filed 2026-03-31
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
100.00K shares
derived: sum of 2 quarters · filed 2026-03-31
125.00K shares
derived: sum of 3 quarters · filed 2026-03-31
1.37M shares
10-K · filed 2026-03-31
2024-09-30100.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
125.00K shares
derived: sum of 2 quarters · filed 2024-11-14
1.37M shares
10-Q · filed 2024-11-14
1.37M shares
derived: sum of 4 quarters · filed 2025-03-31
2024-06-3025.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
1.27M shares
10-Q · filed 2024-08-13
1.27M shares
derived: sum of 3 quarters · filed 2025-03-31
1.50M shares
derived: sum of 4 quarters · filed 2025-03-31
2024-03-311.25M shares
10-Q · filed 2024-05-15
1.25M shares
derived: sum of 2 quarters · filed 2025-03-31
1.47M shares
derived: sum of 3 quarters · filed 2025-03-31
1.47M shares
derived: sum of 4 quarters · filed 2025-03-31
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
225.00K shares
derived: sum of 2 quarters · filed 2025-03-31
225.00K shares
derived: sum of 3 quarters · filed 2025-03-31
1.02M shares
10-K · filed 2025-03-31
2023-09-30225.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
225.00K shares
derived: sum of 2 quarters · filed 2023-11-13
1.02M shares
10-Q · filed 2023-11-13
1.15M shares
derived: sum of 4 quarters · filed 2024-03-29
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
800.00K shares
10-Q · filed 2023-08-14
925.00K shares
derived: sum of 3 quarters · filed 2024-03-29
925.00K shares
derived: sum of 4 quarters · filed 2024-03-29
2023-03-31800.00K shares
10-Q · filed 2023-05-15
925.00K shares
derived: sum of 2 quarters · filed 2024-03-29
925.00K shares
derived: sum of 3 quarters · filed 2024-03-29
1.13M shares
derived: sum of 4 quarters · filed 2024-03-29
2022-12-31125.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
125.00K shares
derived: sum of 2 quarters · filed 2024-03-29
325.00K shares
derived: sum of 3 quarters · filed 2024-03-29
1.07M shares
10-K · filed 2024-03-29
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
200.00K shares
derived: sum of 2 quarters · filed 2022-11-14
945.00K shares
10-Q · filed 2022-11-14
1.34M shares
derived: sum of 4 quarters · filed 2023-03-30
2022-06-30200.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
945.00K shares
10-Q · filed 2022-08-15
1.34M shares
derived: sum of 3 quarters · filed 2023-03-30
1.54M shares
derived: sum of 4 quarters · filed 2023-03-30
2022-03-31745.00K shares
10-Q · filed 2022-05-16
1.15M shares
derived: sum of 2 quarters · filed 2023-03-30
1.34M shares
derived: sum of 3 quarters · filed 2023-03-30
1.54M shares
derived: sum of 4 quarters · filed 2023-03-30
2021-12-31400.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
595.00K shares
derived: sum of 2 quarters · filed 2023-03-30
795.00K shares
derived: sum of 3 quarters · filed 2023-03-30
2.66M shares
10-K · filed 2023-03-30
2021-09-30195.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
395.00K shares
derived: sum of 2 quarters · filed 2021-11-15
2.26M shares
10-Q · filed 2021-11-15
2.26M shares
derived: sum of 4 quarters · filed 2022-03-31
2021-06-30200.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
2.06M shares
10-Q · filed 2021-08-16
2.06M shares
derived: sum of 3 quarters · filed 2022-03-31
2.31M shares
derived: sum of 4 quarters · filed 2022-03-31
2021-03-311.86M shares
10-Q · filed 2021-05-17
1.86M shares
derived: sum of 2 quarters · filed 2022-03-31
2.12M shares
derived: sum of 3 quarters · filed 2022-03-31
2.12M shares
derived: sum of 4 quarters · filed 2022-03-31
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
250.00K shares
derived: sum of 2 quarters · filed 2022-03-31
250.00K shares
derived: sum of 3 quarters · filed 2022-03-31
1.09M shares
10-K · filed 2022-03-31
2020-09-30250.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
250.00K shares
derived: sum of 2 quarters · filed 2020-11-09
1.09M shares
10-Q · filed 2020-11-09
1.09M shares
derived: sum of 4 quarters · filed 2021-03-31
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
845.00K shares
10-Q · filed 2020-08-10
845.00K shares
derived: sum of 3 quarters · filed 2021-03-31
845.00K shares
derived: sum of 4 quarters · filed 2021-03-31
2020-03-31845.00K shares
10-Q · filed 2020-05-11
845.00K shares
derived: sum of 2 quarters · filed 2021-03-31
845.00K shares
derived: sum of 3 quarters · filed 2021-03-31
1.38M shares
derived: sum of 4 quarters · filed 2021-03-31
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
0.00 shares
derived: sum of 2 quarters · filed 2021-03-31
530.00K shares
derived: sum of 3 quarters · filed 2021-03-31
530.00K shares
10-K · filed 2021-03-31
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
530.00K shares
derived: sum of 2 quarters · filed 2019-11-12
530.00K shares
10-Q · filed 2019-11-12
1.06M shares
derived: sum of 4 quarters · filed 2020-03-16
2019-06-30530.00K shares
10-Q · filed 2019-08-09
530.00K shares
10-Q · filed 2019-08-09
1.06M shares
derived: sum of 3 quarters · filed 2020-03-16
1.07M shares
derived: sum of 4 quarters · filed 2020-03-16
2019-03-31530.00K shares
10-Q · filed 2019-05-10
530.00K shares
derived: sum of 2 quarters · filed 2020-03-16
540.00K shares
derived: sum of 3 quarters · filed 2020-03-16
1.08M shares
derived: sum of 4 quarters · filed 2020-03-16
2019-01-31530.00K shares
10-Q · filed 2019-11-12
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
10.00K shares
derived: sum of 2 quarters · filed 2020-03-16
551.88K shares
derived: sum of 3 quarters · filed 2020-03-16
1.01M shares
10-K · filed 2020-03-16
2018-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
551.88K shares
derived: sum of 2 quarters · filed 2018-11-13
1.01M shares
10-Q · filed 2018-11-13
1.51M shares
derived: sum of 4 quarters · filed 2019-03-06
2018-06-30541.88K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
1.00M shares
10-Q · filed 2018-08-14
1.50M shares
derived: sum of 3 quarters · filed 2019-03-06
1.50M shares
derived: sum of 4 quarters · filed 2019-03-06
2018-05-31506.88K shares
10-Q · filed 2018-11-13
2018-03-31460.00K shares
10-Q · filed 2018-05-11
958.38K shares
derived: sum of 2 quarters · filed 2019-03-06
958.38K shares
derived: sum of 3 quarters · filed 2019-03-06
958.38K shares
derived: sum of 4 quarters · filed 2019-03-06
2018-01-31460.00K shares
10-Q · filed 2018-11-13
2017-12-31498.38K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
498.38K shares
derived: sum of 2 quarters · filed 2019-03-06
498.38K shares
derived: sum of 3 quarters · filed 2019-03-06
498.38K shares
10-K · filed 2019-03-06
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
0.00 shares
derived: sum of 2 quarters · filed 2017-11-07
0.00 shares
10-Q · filed 2017-11-07
1.16M shares
derived: sum of 4 quarters · filed 2018-03-29
2017-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
0.00 shares
10-Q · filed 2017-08-14
1.16M shares
derived: sum of 3 quarters · filed 2018-03-29
1.16M shares
derived: sum of 4 quarters · filed 2018-03-29
2017-03-310.00 shares
10-Q · filed 2017-05-15
1.16M shares
derived: sum of 2 quarters · filed 2018-03-29
1.16M shares
derived: sum of 3 quarters · filed 2018-03-29
1.43M shares
derived: sum of 4 quarters · filed 2018-03-29
2016-12-311.16M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
1.16M shares
derived: sum of 2 quarters · filed 2018-03-29
1.43M shares
derived: sum of 3 quarters · filed 2018-03-29
1.43M shares
10-K · filed 2018-03-29
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
277.50K shares
derived: sum of 2 quarters · filed 2017-11-07
277.50K shares
10-Q · filed 2017-11-07
555.00K shares
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30277.50K shares
10-Q · filed 2016-08-09
277.50K shares
10-Q · filed 2017-08-14
555.00K shares
derived: sum of 3 quarters · filed 2017-05-15
705.00K shares
derived: sum of 4 quarters · filed 2017-05-15
2016-03-31277.50K shares
10-Q · filed 2017-05-15
277.50K shares
derived: sum of 2 quarters · filed 2017-05-15
427.50K shares
derived: sum of 3 quarters · filed 2017-05-15
427.50K shares
derived: sum of 4 quarters · filed 2017-05-15
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
150.00K shares
derived: sum of 2 quarters · filed 2017-03-28
150.00K shares
derived: sum of 3 quarters · filed 2017-03-28
454.00K shares
10-K · filed 2017-03-28
2015-09-30150.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
150.00K shares
derived: sum of 2 quarters · filed 2015-11-09
454.00K shares
10-Q · filed 2015-11-09
454.00K shares
derived: sum of 4 quarters · filed 2016-03-15
2015-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
304.00K shares
10-Q · filed 2015-08-10
304.00K shares
derived: sum of 3 quarters · filed 2016-03-15
332.32K shares
derived: sum of 4 quarters · filed 2016-03-15
2015-03-31304.00K shares
10-Q · filed 2015-05-11
304.00K shares
derived: sum of 2 quarters · filed 2016-03-15
332.32K shares
derived: sum of 3 quarters · filed 2016-03-15
332.32K shares
derived: sum of 4 quarters · filed 2016-03-15
2015-01-31304.00K shares
10-Q · filed 2015-11-09
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
28.32K shares
derived: sum of 2 quarters · filed 2016-03-15
28.32K shares
derived: sum of 3 quarters · filed 2016-03-15
354.82K shares
10-K · filed 2016-03-15
2014-09-3028.32K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
28.32K shares
derived: sum of 2 quarters · filed 2014-11-10
354.82K shares
10-Q · filed 2014-11-10
354.82K shares
derived: sum of 4 quarters · filed 2016-03-15
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
326.50K shares
10-Q · filed 2014-08-07
326.50K shares
derived: sum of 3 quarters · filed 2016-03-15
526.50K shares
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31326.50K shares
10-Q · filed 2014-05-13
326.50K shares
derived: sum of 2 quarters · filed 2016-03-15
526.50K shares
derived: sum of 3 quarters · filed 2016-03-15
551.50K shares
derived: sum of 4 quarters · filed 2016-03-15
2014-01-31326.50K shares
10-Q · filed 2014-08-07
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
200.00K shares
derived: sum of 2 quarters · filed 2016-03-15
225.00K shares
derived: sum of 3 quarters · filed 2016-03-15
425.43K shares
10-K · filed 2016-03-15
2013-09-30200.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
225.00K shares
derived: sum of 2 quarters · filed 2013-11-12
425.43K shares
10-Q · filed 2013-11-12
495.43K shares
derived: sum of 4 quarters · filed 2015-03-18
2013-06-3025.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
225.43K shares
10-Q · filed 2013-08-14
295.43K shares
derived: sum of 3 quarters · filed 2015-03-18
545.43K shares
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31200.43K shares
10-Q · filed 2013-05-10
270.43K shares
derived: sum of 2 quarters · filed 2015-03-18
520.43K shares
derived: sum of 3 quarters · filed 2015-03-18
2012-12-3170.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
320.00K shares
derived: sum of 2 quarters · filed 2015-03-18
800.00K shares
10-K · filed 2015-03-18
2012-09-30250.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
730.00K shares
10-Q · filed 2012-11-09
2012-06-30480.00K shares
10-Q · filed 2012-08-10
2011-12-311.68M shares
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63